Riskpilot← Back to searchSign inGet full accessMediPress Oy
OYActiveY-tunnus 3265963-5Suurlohjankatu 26-L3Medical specialists activities · NACE 8622Est. 2022— employees
Revenue 2025
EUR 223K
+2% vs 2024
EBITDA margin
19.5%
+1141% vs 2024
Equity ratio
53.5%
Financial strength
Net profit 2025
EUR 25K
+804% vs 2024
| Revenue | EUR 223K | +2% |
| EBITDA | EUR 43K | +1141% |
| Net profit | EUR 25K | +804% |
| Total assets | EUR 88K | +155% |
| Equity | EUR 47K | +97% |
| Employees | — | — |
Legal name
MediPress Oy
Y-tunnus number
3265963-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
3. helmikuuta 2022
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Yhtiön toimiala: Lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, kauneudenhoitopalvelujen tuottaminen sekä kustannustoiminta ja taiteellisten teosten tuottaminen. Yhtiö voi tuottaa media-, informaatio- ja viestintäalan palveluita. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa. Hevosten ja muiden hevoseläinten kasvatus, Urheilu- ja kipailutoiminta, valmentaminen.
Address
Suurlohjankatu 26-L3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 202 | 219 | 223 |
| Staff expenses | −115 | −135 | −75 |
| EBITDA | 10 | 3 | 43 |
| Depreciation & amort. | −0 | −0 | −12 |
| EBIT | 1 046 | 3 | 32 |
| Net financials | −0 | −0 | −1 |
| Profit before tax | 10 | 3 | 31 |
| Tax | 2 | 1 | 6 |
| Net profit | 794 | 3 | 25 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 3 211 | 34 | 88 |
| Equity | 2 289 | 24 | 47 |
| Long-term debt | 0 | 0 | 31 |
| Short-term debt | 922 | 11 | 9 |
| Total debt | 922 | 11 | 41 |
EBITDA margin
19.5%
This company
15.8%
Market median
+23% vs market
20232025
Equity ratio
53.5%
This company
38.2%
Market median
+40% vs market
20232025
Return on equity
52.6%
This company
18.4%
Market median
+186% vs market
20232025
Net profit margin
11.1%
This company
8.1%
Market median
+37% vs market
20232025
Asset turnover
2.55×
This company
1.12×
Market median
+128% vs market
20232025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NM Chief Executive Officer | Chief Executive Officer | 2022 |
KA Deputy Member | Deputy Member | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MediPress Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Neea Maaria Lehtiö | Chief Executive Officer | 0 companies |
| Karri Antti Valdemar Lehtiö | Deputy Member | 0 companies |